Our clinics & Specialists
Dr. Sung Yong Kang
Sung Yong Kang, MD
Degree and Career
[Medical News] Sung Yong Kang, MD of Eyereum Ophthalmic Clinic, nominated as the 50 world’s most influential ophthalmologist of 2017
Sung Yong Kang, MD of Eyereum Ophthalmic Clinic has been honored to be nominated in The Power List 50 by the European Ophthalmology Journal ‘The Ophthalmologist’ this year. The Power List 50 includes Pears Keane and the 6 medical team members of Moorfields Eye Hospital of U.K., Doctor Alex Huang from Doheny Eye Institute of UCLA, and the world’s most authoritative ophthalmologists with Sung Yong Kang, MD being the only Korean doctor.
‘The Power list’ of the Ophthalmologist has been nominating the 50 world’s most influential ophthalmologists annually and this year, with their new theme ‘Rising Star’, they proceeded an early vote on the subject of the world’s note-worthy medical teams, with the participants of the ophthalmology field. According to the European local presses, Sung Yong Kang, MD is a doctor to represent the Asian region and his active academic activities and papers have been recognized to be nominated in the Power List 50. Sung Yong Kang, MD of the great medical cases in the adverse reaction field and the SCI papers has been lecturing in the world’s academic society, on the subjects of laser vision correction, light sensitivity issues after LASIK/LASEK, regression in vision, and keratoconus(Keratectasia). His paper from last year about COWAVE to prevent and cure optical side effects has been officially selected in the SCI graded academic journal, JCRS(Journal of Cataract & Refractive Surgery) and with the world’s great scholars, he investigated and established the normal range and the general index for safety in cornea durability(rigidity) to prevent keratoconus, and as a result, he succeeded to transfer the normal value of cornea durability of Asians’ eyes to the general index for safety statistically.
Sung Yong Kang, MD with his continuous researches covering all fields in ophthalmology and international academic activities, he has accomplished a research achievement worthy of close attention in ReLEX SMILE field. Moreover, he has suggested the low energy SMILE LASIK to prevent the optical side effects and to improve the quality in vision, based on the references such as the differences in bubble production, the restoration speed of visual acuity, and effects in correction of higher order aberration, over the laser energy strength at the cornea lenticule separation stage in SMILE surgery. In other words, the low energy SMILE LASIK means to low the laser equipment’s energy intensity to the critical point where the cornea desquamation is possible, in the operation and minimize the occurrence of gas-bubbles in the cornea so after the operation, the blue symptoms are improved and the cornea is left smooth. As a result, the night vision and light sensitivity issues caused by the higher order aberration are reduced and the clearer visions are achieved.
The outstanding result in the operation of low energy SMILE LASIK has drawn attentions internationally and Dan Z. Reinstein of U.K., an authority in ReLEX SMILE, has participated in the joint research. The research led the Korean doctor to an academic award from the Korean Ophthalmological Society.
In this May, the effect of improvement in vision from the low energy SMILE LASIK was officially selected by AJO (American Journal of Ophthalmology), the highly cited researcher with the paper citation index of 4.021 and the SCI graded academic journal. The participant of the Ophthalmic Clinic has said stated that it is beyond just the international activities or a individual honor of a Korean doctor but, it is rather more meaningful since this results in reporting Korea’s medical improvements and the take-off as a powerful medical nation.